Medical/Pharmaceuticals
Kazia calls for greater awareness of the deadliest gynecological cancer in the US
SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal gynaecological cancer in the US. In 2019, around 22,530 women will receive a new d...
2019-05-08 20:00
6269
United Imaging Healthcare uPMR 790 HD TOF PET/MR Cleared by FDA
HOUSTON, May 8, 2019 /PRNewswire/ -- United Imaging Healthcare (UIH), an international leader in advanced medical imaging and radiotherapy equipment, announced the U.S. Food and Drug Administration (FDA) clearance of the uPMR 790 HD TOF PET/MR. uPMR 790 redefines clinical routine imaging for PET/...
2019-05-08 20:00
1134
Vietnam's "K Hospital" Uses Elekta Solutions to Make Precision Radiation Medicine Available to Cancer Patients
HANOI, Vietnam, May 8, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today thatVietnam's National Cancer Hospital, which is affiliated with the K Hospital, will soon begin treating cancer patients with advanced technology from Elekta. The K hospital has invested in a Leksell Gamma Knife® Icon...
2019-05-08 14:36
1323
Kazia calls for greater awareness of the most lethal women's disease in Australia
SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal women's disease in Australia. Every year, approximately 1,600 Australian women are...
2019-05-08 09:55
6354
GeneQuantum Healthcare completed nearly RMB 100 million in Pre-B financing
SUZHOU, China, May 7, 2019 /PRNewswire/ -- GeneQuantum Healthcare announced that it has closed nearlyRMB 100 million Pre-B round of financing. This financing was led by Huagai Capital, joined by Hofon Capital and Changjinboya. GeneQuantum Healthcare's A-round investor Oriza Seed and TF Capital co...
2019-05-08 08:00
1448
Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints
SUZHOU, China, May 8, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company ("Lilly") jointly announced today that IBI301, a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody being co-developed as a potential bios...
2019-05-08 08:00
8077
Canopy Growth Introduces Spectrum Therapeutics
SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Sp...
2019-05-07 22:31
7083
Agfa Earns Acclaim from Frost & Sullivan for the Enhanced Diagnostic Capability and Flexibility of its Multi-purpose DR 800 System
SANTA CLARA, California, May 7, 2019 /PRNewswire/ -- Based on its recent analysis of the global multipurpose digital radiography (DR) systems market, Frost & Sullivan recognizesAgfa NV (Agfa) with the 2019 Global New Product Innovation Award for its DR 800 multi-purpose system. The product combin...
2019-05-07 20:07
1089
CPHI to Hold First Quarter 2019 Earnings Conference Call On Wednesday, May 15, 2019 at 8:30 a.m. ET
HAIKOU, China, May 7, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2019 earnings conference c...
2019-05-07 20:00
7244
Half-year Figures: ZEISS Innovations Help Achieve Strong Growth
OBERKOCHEN, Germany, May 7, 2019 /PRNewswire/ -- The ZEISS Group had a successful end to the first six months of fiscal year 2018/19 (ended31 March 2019) and saw its revenue rise by 9 percent to EUR 3.019 billion (1st six months of 2017/18:EUR 2.773 billion). At EUR 443 million, earnings before ...
2019-05-07 16:06
1664
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast
Four patients enrolled and treated by sports medicine surgeon Dr. Scott Hacker, MD KFAR SABA, Israel, May 7, 2019 /PRNewswire/ -- Scott A. Hacker, MD, a sports medicine orthopedic surgeon at Grossmont Hospital,San Diego, CA, enrolled and surgically treated the first four patients in the U.S....
2019-05-07 15:00
1074
Saudi Ministry of Health Makes Access to Health Services Easier With New Online Appointment App "MAWID"
RIYADH, Saudi Arabia, May 7, 2019 /PRNewswire/ -- Worldwide, e-Health is playing a significant role in driving healthcare evolution. According to the World Health Organization, healthcare costs globally are increasing by nearly 5% annually and health systems see e-Health as contributing significa...
2019-05-07 14:00
2262
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
YOKNEAM, Israel, May 7, 2019 /PRNewswire/ -- Rapid Medical
2019-05-07 09:00
1465
Innovation Tour on Medical Design and Manufacturing; Medtec China 2019 Visitor Registration Initiated
SHANGHAI, May 7, 2019 /PRNewswire/ -- The 15th Exhibition of Medical Device Design & Manufacturing inChina (Medtec China 2019) will be held from September 25–27 inShanghai. As a leading international exhibition of medical device design and manufacturing inChina, Medtec China will gather 450+ exhi...
2019-05-07 09:00
2248
Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore
Launch of Activated Form of Critical Bacteria B. Infantis in Asia Fulfills Li Ka Shing Foundation's Vision, Caps First Quarter of Major Activity in the Continent DAVIS, California, May 7, 2019 /PRNewswire/ -- Evolve BioSystems, makers of Evivo® baby probiotic, today announced that its flagship c...
2019-05-07 05:00
2055
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certifi...
2019-05-06 21:00
1968
Bardy Diagnostics Earns Acclaim from Frost & Sullivan for Its Groundbreaking Carnation Ambulatory Monitor™ Patch for Arrhythmia Monitoring
CAM™'s unique P-wave-centric ECG monitor offers unmatched signal clarity and superior arrhythmia detection SANTA CLARA, California, May 6, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote cardiac monitoring market, Frost & Sullivan recognizesBardy Diagnostics, Inc. ...
2019-05-06 20:00
1284
Frost & Sullivan Publishes Annual Update on Cellect
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 18:11
859
Frost & Sullivan Publishes Annual Update on Brainsway
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 17:57
860
Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201
TAICANG, China, May 6, 2019 /PRNewswire/ -- Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody, CBP-201. The randomized, double-blind, placebo-controlled study, conducted inMelbourne, Australia, evaluated t...
2019-05-06 17:00
887
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 317 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 287 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
10036
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7286
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
6451
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
6062
